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Abstract
Background: Apples possess rich content of varied polyphenolic compounds showing a variety of biological
activities that may ascribe to worthy effects against some chronic diseases. The present study was designed to
assess the protective effects of the cloudy apple juice (CAJ) and apple peel extract (APE) of Egyptian Anna apple on
the complications in experimental diabetes.
Materials and methods: Four groups were studied. Diabetes was induced by a single dose of streptozotocin (STZ)
to only three groups of albino Wistar rats. Two of the diabetic groups received either CAJ or APE for 21 days. At the
end of the study, lipid profile parameters were measured in serum while lipid peroxidation (LPO) level, antioxidant
enzyme activities and inflammatory markers were evaluated in pancreas tissue samples. The gas chromatography–
mass spectrometry (GC-MS) analysis of phenolic compounds found in CAJ and APE was carried out. Moreover, total
phenolic content of CAJ and APE were measured.
Results: The significant increase of blood glucose level, serum total cholesterol (TC), triglycerides (TG), low-
density lipoprotein cholesterol (LDL-C), and very low-density lipoprotein (VLDL) levels, in addition to tissue
malondialdehyde (MDA), nuclear factor kappa B (NF-kB), tumor necrosis factor α (TNF-α), interleukin 6 (IL-6),
interleukin 8 (IL-8) levels, but a significant decrease in high-density lipoprotein cholesterol (HDL-C), and the activity
of pancreatic antioxidant enzymes were the remarkably parameters observed in diabetic control rats. Dissimilarly,
oral supplementation of 15 ml/kg CAJ and 1 g/kg APE for 21 days resulted in a significant decrease in fasting blood
glucose, serum TC, TG, LDL-C, VLDL-C and tissue MDA, NF-kB, TNF-α, IL-6, IL-8 levels coupled with a significant
elevation of HDL-C and antioxidant enzymes’ activity when compared with diabetic control animals.
Conclusions: The results indicate that Egyptian CAJ and APE supplementation may have protective effects against
deleterious complications of diabetes mellitus.
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Background
Diabetes mellitus (DM) is a major endocrine disorder and
it is expected to increase worldwide by more than 100 %
between 2000 and 2030 [1]. The effects of DM are devastat-
ing, which include the relative depletion of insulin secre-
tion, hyperglycemia and altered metabolism of proteins,
lipids and carbohydrates in addition to damage to the beta
cells (β-cells) of pancreas and an increased risk of other
serious complications of vascular diseases [2, 3]. Moreover,
it was suggested that generation of free radicals is involved
in the pathogenesis of diabetes, and the development of
diabetic complications is due to the prolonged exposure to
hyperglycemia that increases the formation of reactive oxy-
gen species (ROS) via auto-oxidation of glucose and non-
enzymatic protein glycation, which may cause disruption of
cellular functions and oxidative damage to membranes. An
elevation of ROS can cause an impairment of the antioxi-
dant defense system or inability to scavenge the oxidative
damage [4].
A correlation was detected between chronic low-grade
inflammation and type 1 DM which is associated with a sig-
nificant increase of serum biomarkers of inflammation such
as IL-6 and TNF-α [5–8]. The leak out of various cytokines
into the circulation of diabetic patients was observed [9].
These inflammatory cytokines were thought to be involved
in the propagation of the disease and proposing a new role
of inflammation via destruction of β-cells [9]. NF-kB is a
critical transcription factor in inflammation, and its activa-
tion had been proven to upregulate gene expression of
other pro-inflammatory cytokines [10]. It was suggested
that NF-kB pathway regulates the production of the che-
mokine IL-8, which is one of the main mediators of inflam-
matory response [11]. Additionally, improper activation of
NF-kB signaling pathway is associated with the appearance
of many diseases including DM [11].
Streptozotocin (STZ) is a potent antibiotic, which is
involved in the development of chemically-induced
DM in experimental animals through its action on
pancreatic β-cells [12]. The diabetogenic and cytotoxic
effects of STZ are associated with the production of
free radicals causing oxidative injury to the cells and
also coupled with propagation of diabetes-linked auto-
immunity [13–15]. High reactivity of ROS exerts toxic
effects on the pancreatic acinar cells and is linked
with inflammatory mediators’ production [16].
It has been reported that plasma thiobarbituric acid level
increased in diabetic patients due to vascular lesions in-
duced by hyperglycemia [17]. Lipid peroxidation was shown
to be capable of initiating the secondary complications of
diabetes. The level of ROS is modulated by the antioxi-
dants, both enzymatic and non-enzymatic. Antioxidant
enzymes such as superoxide dismutase (SOD), glutathione
peroxidase (GPx), and catalase (CAT), while non-enzymatic
antioxidants like reduced glutathione (GSH). In diabetes,
oxidative stress results from the excessive generation of
ROS, either by excess production or insufficient removal as
a result of a sharp depletion of antioxidant potential [18].
Renewed attention to alternative medicines and nat-
ural therapies has animated new wave of research to
look for more effective agents with lesser side effects
[19]. Naturally occurring phytochemicals with antihy-
perglycemic activities are more favorable because they
are commonly used to prevent morbidity and mortal-
ity from chronic diseases in countries with low or
middle-income populations [20]. The widespread and
increasing intake of apple juice/products and their
rich phytochemical profile suggest their important po-
tential to improve the health of populations consum-
ing them [21]. Apples, the most consumed fruits of
temperate climate countries, are a considerable source
of phenolic compounds in the human diet [22]. Sun
et al., showed that apples take the second position
among fruits for the total phenolic compounds’ con-
centration [23]. Several studies have shown that ap-
ples have a wide variety of that may ascribe to health
beneficial effects against cancer, cardiovascular dis-
eases, asthma and pulmonary dysfunction, Alzheimer’s
disease, decline of normal aging, weight management,
bone health, diabetes and gastrointestinal protection
[21]. In addition, apples have exhibited antioxidant
and anti-inflammatory effects due to their phytochem-
icals and flavonoids contents [24, 25]. All these stud-
ies have supported the age-old saying “an apple a day
keeps the doctor away”.
However, to the best of our knowledge, the present
experimental study is a first-ever to analyze the Egyptian
apple juice and peel phenolic profile and to evaluate
their ameliorative potential on hyperglycemia, hyperlip-
idemia, pancreatic lipid peroxidation, pro-inflammatory




Thirty two male albino Wistar rats (150–200 g) were
housed in a temperature controlled room under 12/12 h
light/dark cycle and had free access to pellet and tap
water ad libitum.
This study was carried out in strict compliance with the
Guidelines of Animals Health Research Institute, Egypt.
The study protocol was approved by the Committee on
the Ethics of Animals Health Research Institute, Egypt
(Permit Number 362 approved on August 31, 2010). All
the experimental procedures were carried out in accord-
ance with NIH guide for the care and use of laboratory
animals and with approval from the Local Animals Ethics
Committee of NCI, Cairo University, Egypt.
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Apple source and identification
Egyptian Anna apple (Malus domestica Borkh) fruits were
harvested at Nubaria city, Egypt. The plant was identified
by matching it with well identified specimens kept at the
Herbarium of Flora Researches Centre at the Agriculture
museum campus (CAIM), Dokki, Giza, Egypt.
Preparation of CAJ and APE
Ten kg of Anna apple (Malus domestica Borkh) fruits
were washed and manually peeled. CAJ was obtained
using commercial blender (Braun, Germany), and im-
mediately stored at –20 °C for no longer than
2 months.
The APE was prepared according to Reagan-Shaw et
al. [26]. The apples were washed in ddH2O, dried, and
peeled using an autoclaved kitchen peeler then the
peels were left to dry. Peels were homogenized at high
speed with 2.5 ml ddH2O/g peel. The extract was
centrifuged twice at 5000 g for 15 min and a third time
at 10,000 g for 15 min. The supernatant was filter
sterilized, aliquoted, and stored at –20 °C.
Chemicals
Streptozotocin (STZ) was obtained from MP Biomedicals,
LLC (lllkirch, France). All other chemicals used were of
analytical grade.
Induction of diabetes
The animals were fasted for 16 h prior to the induction
of diabetes. STZ, freshly prepared in citrate buffer
(0.1 M, pH 4.5), was administered intraperitoneally (i.p.)
at a single dose of 60 mg/kg body weight. Development
of diabetes was confirmed by polydipsia, polyuria and by
determining glucose concentrations three days after in-
jection of STZ. Rats with a blood glucose level of
250 mg/dl or above were considered to be diabetic. The
treatment was initiated on the 4th day after the injection
of the STZ that was considered the first day of treatment
and it was carried on continuously for 3 weeks.
Experimental design
The rats were randomly assigned to 4 different treat-
ment groups of 8 animals each. At the beginning of the
experiment, each of the three diabetic groups received
single dose of STZ in citrate buffer while the normal
control group received citrate buffer only. The groups
separated as indicated below.
Group I: normal control rats received citrate buffer
(pH 4.5) (1 ml/kg. i.p.).
Group II: Diabetic control rats received a single dose
of STZ (60 mg/kg. i.p.).
Group III: CAJ treated diabetic rats received CAJ
(15 ml/kg/day; by gavage) on the 4th day following STZ
injection and continued for 21 days.
Group IV: APE treated diabetic rats received APE
(1 g/kg/day; by gavage) on the 4th day after STZ injec-
tion and continued for 21 days.
Blood and tissue sampling
On the last day of the experiment, blood samples were
collected for biochemical examinations. The samples
were left for 30 min at room temperature and then cen-
trifuged at 2000 g for 15 min at 4 °C for serum separ-
ation. The samples were kept frozen at –80 °C for the
estimation of lipid profile parameters. Afterwards, the
animals were decapitated and pancreas was immediately
removed, rinsed in ice-cold phosphate buffered saline
(0.1 M, pH 7.4) and weighed before homogenization.
The minced tissue was homogenized in PBS and was
sonicated. After that, the homogenates were centrifuged
for 5 min at 5000 g at 4 °C to obtain the supernatant.
Part of the supernatant was kept frozen at –80 °C for
the estimation of MDA level and the activity of antioxi-
dant enzymes; CAT, GR (glutathione reductase), GPx,
and SOD while the other part was stored at ≤ –20 °C for
determination of NF-kB, TNF-α, IL-6 and IL-8 levels.
Gas chromatography–mass spectrometry (GC-MS) analysis
The analysis was carried out using a GC (Agilent
Technologies 7890A) interfaced with a mass-selective
detector (MSD, Agilent 7000 Triple Quad) equipped
with an apolar Agilent HP-5 ms (5 %-phenyl methyl
poly siloxane) capillary column (30 m × 0.25 mm i. d.
and 0.25 μm film thickness). The carrier gas was he-
lium with the linear velocity of 1 ml/min. The injector
and detector temperatures were 200 °C and 250 °C,
respectively. Injection mode, split; split ratio 1: 10,
volume injected 1 μl of the sample. The MS operating
parameters were as follows: ionization potential 70 eV,
interface temperature 250 °C, and acquisition mass
range 50–600. The identification of components was
based on a comparison of their mass spectra and re-
tention time with those of the authentic compounds
and by computer matching with NIST and WILEY li-
brary as well as by comparison of the fragmentation
pattern of the mass spectral data with those reported
in the literature [27].
Determination of the total phenolic content in CAJ and
APE
The Folin–Ciocalteu method was used to determine
total phenolic content [28]. Gallic acid was used as a
standard and the determination was performed using
spectrophotometer at 760 nm. All determinations were
carried out in triplicate and results were expressed as
percentage ± standard deviation (S.D.).
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Biochemical measurements
Blood glucose
Blood glucose was estimated using one touch glucometer
(Accu check Roche, Germany).
Lipid profile parameters
Serum total cholesterol (TC) [29], total triglycerides
(TG) [30], low-density lipoprotein cholesterol (LDL-C),
very-low density lipoprotein cholesterol (VLDL-C) [31]
and high-density lipoprotein cholesterol (HDL-C) [32]
were determined by using standard colorimetric kits
(Biosystems, Barcelona, Spain).
Estimation of pancreatic biochemical parameters
Measurement of MDA Lipid peroxidation (LPO) in
tissue homogenate was measured by thiobarbituric acid
(TBA) reaction with MDA, a product formed due to
the peroxidation of lipid membranes [33]. After a brief
incubation, the samples were read spectrophotometi-
cally at 532 nm (OxiSelectTBARS Assay kit; MDA
Quantitation kit, CellBiolabs, Inc., CA, USA).
GR assay GR activity in tissue homogenate was assayed
using a method based on GR reduces GSSG to GSH,
which reacts with 5-(3-carboxy-4-nitrophenyl) disulfanyl-
2-nitrobenzoic acid (DNTB) to generate TNB2−yellow
color that was measured at 405 nm using a commercial
available kit (BioVision, CA, USA) according to the manu-
facturer’s instructions.
CAT assay CAT activity was measured using a CAT
assay kit (Calbiochem, Germany) according to the man-
ufacturer’s instructions. The method based on the reac-
tion of the enzyme with methanol in the presence of an
optimal concentration of H2O2. The formaldehyde pro-
duced was measured spectrophotometrically with 4-
amino-3-hydrazino-5-mercapto-1,2,4-triazole (Purpald)
as the chromagen [34]. Absorbance was read at 540 nm.
SOD assay SOD activity was measured using OxiSelect
SOD kit (CellBiolabs, Inc., CA, USA) according to the
manufacturer’s instructions. The method based on the
generation of superoxide anions (O2
−) by a xanthine/
xanthine Oxidase (XOD) systems, and then detected with
a chromagen solution [35]. Absorbance was measured at
540 nm.
GPx assay GPx activity was measured using Abnova kit
(Taipei, Taiwan) according to the manufacturer’s instruc-
tions. In this assay, NADPH consumption was assessed
by the enzyme coupled reactions [36]. The measured
decrease in absorbance at 340 nm is directly propor-
tional to the enzyme activity in the sample.
NF-kB, TNF-α, IL-6, and IL-8 measurement and
ELISA NF-kB, TNF-α, IL-6, and IL-8 levels were
measured in the supernatant of the pancreatic tissue by
enzyme-linked immunosorbent assay (ELISA) following
the manufacturer’s instructions from (Millipore, CA.).
One hundred microlitres of each supernatant was mixed
with the assay buffer according to manufacturer’s instruc-
tions. The absorbance was determined spectrophotomet-
rically at 450 nm± 2 nm.
Statistical analysis
Data were presented as means ± S. D. Data were ana-
lyzed by one-way analysis of variance (ANOVA) and sig-
nificant differences were determined by Duncan’s
multiple range test at 5 % level using statistical package
for social science (SPSS 17, SPSS Inc. Chicago, IL, USA).
Differences among groups were considered statistically
significant at p < 0.05.
Results
GC-MS analysis
Polyphenolic compounds of CAJ
GC-MS analysis of CAJ revealed the presence of different
polyphenolic compounds. Those compounds include:
Emodin (1,3,8-trihydroxy-6-methylanthracene-9,10-dione);
Kaempferol (3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-
chromen-4-one); Cyanidin cation [2-(3,4-dihdroxyphenyl)-
3,5,7-trihydroxychromenylium]; Stevioside (13-[(2-O-beta-
D-Glucopyranosyl-alpha-D-glucopyranosyl)oxy]kaur-16-
en-18-oic acid beta-D-glucopyranosyl ester) and Butylated
hydroxytoluene (2,6-Bis(1,1-dimethylethyl)-4-methylphenol)
(Table 1, Figs. 1 and 2).
Polyphenolic compounds of APE
GC-MS analysis of APE showed the presence of many
various polyphenolic compounds. Those compounds
include: (+)-Catechin [(2R,3S)-3′,4′,5,7-tetrahydroxyfla-
van-3-ol]; Resorcinol (Benzene-1,3-diol); Hydroquinone,
2,6-di-tert-butyl- [(1,4 benzenediol, 2,6-bis (1,1 dimethy-
lethyl)]; Resveratrol (3,5,4′-trihydroxy-trans-stilbene);




2,3,6,7,8a hexahydro-1,4,9,9 tetramethyl-(1.alpha., 3a.
alpha., 7. alpha., 8a. beta)]; Sinapic acid [3-(4-hydroxy-3,5-
dimethoxyphenyl)prop-2-enoic acid]; Geranyl isovalerate
(Trans-3,7 dimethyl-2,6-octadien-1-YL isopentanoate)
and β-Humulene (1,4,4-trimethyl-8-methylenecycloundeca-
1,5-diene) (Table 2, Figs. 3 and 4).
Total phenolic contents in CAJ and APE
It was found that the total amount of phenolic compounds
in CAJ are 69.68 ± 2.17 mg of gallic acid equivalents/
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100 ml of juice whereas the total phenolic content in APE
are 673.46 ± 6.90 mg of gallic acid equivalents/100 g DW.
Effect of CAJ and APE supplementation on hyperglycemia
in experimental animals
The levels of blood glucose in normal and diabetic rats
are presented in Table 3. In all groups prior to STZ injec-
tion, the basal level of blood glucose of the rats was not
markedly different. However, there was a significant eleva-
tion in blood glucose level after STZ injection. Although a
significant antihyperglycemic effect was obvious from the
first week onwards, the reduction in blood glucose was
maximum on the third week in diabetic group receiving
CAJ. After STZ injection, a significant increase in blood
glucose was observed in diabetic control rats as compared
with normal control rats (P < 0.05). The administration of
CAJ and APE significantly decreased glucose levels in
diabetic rats when compared with diabetic control group
(P < 0.05). Moreover, CAJ and APE treated diabetic groups
exhibited insignificant differences when compared with
normal control rats. Therefore, the levels of blood glucose
reverted close to normal range in diabetic rats treated with
CAJ and APE.
Effect of CAJ and APE supplementation on hyperlipidemia
in experimental animals
Table 4 indicates the serum levels of lipid TC, TG, HDL-C,
LDL-C and VLDL-C in normal and experimental animals.







1 Emodin (1,3,8-trihydroxy-6-methylanthracene-9,10-dione) 20.88 33.78 270
2 Kaempferol (3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one) 20.62 6.01 286
3 Cyanidin cation [2-(3,4-dihdroxyphenyl)-3,5,7-trihydroxychromenylium] 18.29 1.16 287
4 Stevioside (13-[(2-O-beta-D-Glucopyranosyl-alpha-D-glucopyranosyl)
oxy]kaur-16-en-18-oic acid beta-D-glucopyranosyl ester)
7.77 1.63 804
5 Butylated hydroxytoluene (2,6-Bis(1,1-dimethylethyl)-4-methylphenol) 19.94 0.43 220
Fig. 1 Total ion chromatograms of GC/MS analysis of Egyptian CAJ. a: Emodin (1,3,8-trihydroxy-6-methylanthracene-9,10-dione); b: Kaempferol
(3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one); c: Cyanidin cation [2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromenylium]; d: Stevioside
(13-[(2-O-beta-D-Glucopyranosyl-alpha-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid beta-D-glucopyranosyl ester); e: Butylated
hydroxytoluene (2,6-Bis(1,1-dimethylethyl)-4-methylphenol)
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Fig. 2 GC/MS fragmentation patterns of polyphenolic compounds in Egyptian CAJ. a: Emodin (1,3,8-trihydroxy-6-methylanthracene-9,10-dione); b:
Kaempferol (3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one); c: Cyanidin cation [2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromenylium];
d: Stevioside (13-[(2-O-beta-D-Glucopyranosyl-alpha-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid beta-D-glucopyranosyl ester); e: Butylated
hydroxytoluene (2,6-Bis(1,1-dimethylethyl)-4-methylphenol)







1 (+)-Catechin [(2R,3S)-3′,4′,5,7-tetrahydroxyflavan-3-ol] 14.82 1.13 290
2 Resorcinol (Benzene-1,3-diol) 14.31 1.69 110
3 Hydroquinone, 2,6-di-tert-butyl- [1,4 benzenediol, 2,6-bis (1,1 dimethylethyl)] 14.8 2.31 222
4 Resveratrol (3,5,4′-trihydroxy-trans-stilbene) 22.3 0.5 228
5 Fisetin (3, 7, 3′, 4′-tetrahydroxyflavone) 18.31 0.56 286
6 Cyanidin cation [2-(3,4-dihdroxyphenyl)-3,5,7-trihydroxychromenylium] 18.29 1.21 287
7 Butylated hydroxytoluene (2,6-Bis(1,1-dimethylethyl)-4-methylphenol) 19.94 1.91 220
8 Patchoulene [1H-3a,7methanoazoulene, 2,3,6,7,8a hexahydro-1,4,9,9
tetramethyl-(1.alpha., 3a. alpha., 7. alpha., 8a. beta)]
12.01 5.99 204
9 Sinapic acid [3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid] 11.89 3.89 224
10 Geranyl isovalerate (Trans-3,7 dimethyl-2,6-octadien-1-YL isopentanoate) 16.29 0.73 238
11 β-Humulene (1,4,4-trimethyl-8-methylenecycloundeca-1,5-diene) 11.43 4.81 204
Fathy and Drees BMC Complementary and Alternative Medicine  (2016) 16:8 Page 6 of 14
STZ injection led to a significant elevation of TC, TG,
LDL-C, VLDL-C and reduction in HDL-C levels when
compared to the normal control rats (P < 0.05). There was
a significant reduction in TC, TG, LDL-C, VLDL-C in
diabetic rats treated with CAJ and APE as compared with
diabetic control rats (P < 0.05). A pronounced elevation of
HDL-C in diabetic groups receiving CAJ and APE, as com-
pared with diabetic control rats, was recorded (P < 0.05).
Notably, all lipid profile parameters were reversed close to
normal control levels following CAJ and APE supplementa-
tions as the differences were insignificant among CAJ
treated diabetic, APE treated diabetic and normal control
groups.
Effect of CAJ and APE supplementation on pancreatic
lipid peroxidation (LPO) in experimental animals
Table 5 shows the effect of CAJ and APE administration on
MDA levels in pancreatic tissue of diabetic rats. There was
a significant elevation in tissue MDA in diabetic rats as
compared with normal control rats (P < 0.05). Treatment of
diabetic rats with CAJ and APE for 21 days results in a
marked decrease in pancreatic MDA when compared with
diabetic control rats (P < 0.05). Meanwhile, the differences
were significant between both CAJ and APE treated
diabetic rats in relation to normal control group (P < 0.05).
Effect of CAJ and APE supplementation on pancreatic
antioxidant enzymes activities in experimental animals
As presented in Table 5, the activities of enzymatic
antioxidants (CAT, GR, GPx and SOD) in pancreas of
normal control, diabetic control and diabetic treated
rats. CAT, GR, GPx and SOD activities were signifi-
cantly depleted in diabetic control rats as compared
with normal control rats (P < 0.05). A significant im-
provement in the activities of these enzymes after oral
administration of CAJ and APE, when compared with
diabetic control rats, was recorded (P < 0.05). Regard-
ing CAT, GPx and SOD activities, significant varia-
tions were observed among diabetic control, CAJ
treated diabetic and APE treated diabetic groups (P <
0.05). However, GR activity showed a significant dif-
ference between APE treated diabetic group compared
to either normal control group or CAJ treated dia-
betic rats (P < 0.05).
CAJ and APE attenuated the production of NF-kB, TNF-α,
IL-6, and IL-8in diabetic rats
Figure 5 revealed that STZ significantly increased the
production of the pancreatic pro-inflammatory markers;
NF-kB, TNF-α, IL-6, and IL-8 as compared with the nor-
mal control rats (P < 0.05). Meanwhile, treatment with
CAJ and APE significantly reduced the levels of those in-
flammatory mediators when compared with diabetic
control group (P < 0.05).
Regarding the level of NF-kB, diabetic control group
showed a significant elevated NF-kB level in relation to
normal control rats (P < 0.05); whereas the treatment
with both CAJ and APE significantly reduced NF-kB
levels as compared to diabetic control group (P < 0.05).
Although CAJ treatment reversed NF-kB level towards
normal control level, a significant difference in the level
of NF-kB was recorded between APE supplemented
Fig. 3 Total ion chromatograms of GC/MS analysis of Egyptian APE. a: (+)-Catechin [(2R,3S)-3′,4′,5,7-tetrahydroxyflavan-3-ol]; b: Resorcinol
(Benzene-1,3-diol); c: Hydroquinone, 2,6-di-tert-butyl- [1,4 benzenediol, 2,6-bis (1,1 dimethylethyl)]; d: Resveratrol (3,5,4′-trihydroxy-trans-stilbene);
e: Fisetin (3, 7, 3′, 4′-tetrahydroxyflavone); f: Cyanidin cation [2-(3,4-dihdroxyphenyl)-3,5,7 trihydroxychromenylium]; g: Butylated hydroxytoluene
(2,6-Bis(1,1-dimethylethyl)-4-methylphenol); h: Patchoulene [1H-3a,7methanoazoulene, 2,3,6,7,8a hexahydro-1,4,9,9 tetramethyl-(1.alpha., 3a.
alpha., 7. alpha., 8a. beta)]; i: Sinapic acid [3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid]; j: Geranyl isovalerate (Trans-3,7
dimethyl-2,6-octadien-1-YL isopentanoate)
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Fig. 4 GC/MS fragmentation patterns of polyphenolic compounds in Egyptian APE. a: (+)-Catechin [(2R,3S)-3′,4′,5,7-tetrahydroxyflavan-3-ol]; b:
Resorcinol (Benzene-1,3-diol); c: Hydroquinone, 2,6-di-tert-butyl- [1,4 benzenediol, 2,6-bis (1,1 dimethylethyl)]; d: Resveratrol (3,5,4′-trihydroxy-trans-stilbene);
e: Fisetin (3, 7, 3′, 4′-tetrahydroxyflavone); f: Cyanidin cation [2-(3,4-dihdroxyphenyl)-3,5,7 trihydroxychromenylium]; g: Butylated hydroxytoluene (2,6-Bis
(1,1-dimethylethyl)-4-methylphenol); h: Patchoulene [1H-3a,7methanoazoulene, 2,3,6,7,8a hexahydro-1,4,9,9 tetramethyl-(1.alpha., 3a. alpha., 7. alpha., 8a.
beta)]; i: Sinapic acid [3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid]; j: Geranyl isovalerate (Trans-3,7 dimethyl-2,6-octadien-1-YL isopentanoate)
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diabetic group when compared with normal control rats
(P < 0.05).
In addition, TNF-α level was significantly enhanced in
diabetic control rats in relation to normal control group
(P < 0.05); while CAJ and APE supplementations reduced
the levels of TNF-α as compared with diabetic control
group (P < 0.05). Moreover, the difference between either
CAJ or APE treated diabetic groups was significant in
relation to normal control group (P < 0.05).
Regarding the level of IL-6, it was found that the dia-
betic control group have a significantly elevated level
when compared with normal control level (P < 0.05).
Meanwhile the treatment of diabetic rats with either
CAJ or APE significantly reduced IL-6 levels as com-
pared to diabetic control rats (P < 0.05) and ameliorated
the IL-6 levels close to normal control group. However,
a significant difference was detected between APE
treated diabetic group as compared with both normal
control and CAJ treated diabetic rats (P < 0.05).
On the other hand; the level of IL-8 diabetic control
group showed a highly significant increase in compari-
son with normal control group (P < 0.05); whereas, IL-8
level was decreased with CAJ and APE treatments com-
pared to diabetic control group (P < 0.05). Notably, sig-
nificant differences among IL-8 levels of CAJ treated
diabetic, APE treated diabetic and normal control groups
were detected (P < 0.05).
Discussion
Several studies have addressed the link between dietary fruit
and vegetables’ consumption in relation to improved health
in human. Fruit and vegetables are precious source of many
biologically active components including antioxidants,
which play a key role as chemopreventive agents and pos-
sessing a clear effect on retarding the development of
serious chronic diseases’ complications [37]. Apples are
known to be rich in flavonoid antioxidants including epica-
techins, catechins, and procyanidins which are the major
phytochemicals in the human diet [38]. Although apples
and apple products have been shown to exert positive
effects in numerous pathologies [39], the preventive activity
of Egyptian Anna apple against chemically induced diabetes
has not been explored.
In the current work, supplementation of CAJ and APE
for 21 days shows antihyperglycemic effect in STZ-
induced diabetic rats. Such results are in agreement with
previous reports that proved antihyperglycemic effects of
pomegranate, black tea, and green tea in chemically in-
duced diabetic animals [40–42].
The present polyphenolic investigation of CAJ and
APE demonstrated the finding of bioflavonoids that may
have a role in the stimulation of glucose uptake in per-
ipheral tissues and regulation of the expression and/or
activity of the enzymatic committed steps involved in
carbohydrate metabolism [43]. Further study is required
to estimate the impact of CAJ and APE on the activity
and/or expression of such enzymes.
Hyperlipidemia is a recognized consequence of DM and
also is one of the major cardiovascular risk factors. Dia-
betes induced hyperlipidemia is ascribed to a variety of
derangement in regulatory and metabolic processes which
coming from the excess mobilization of fats from adipo-
cytes due to less utilization of glucose caused by insulin
deficiency, which consequently leads to accumulation of
lipids such as TC and TG in diabetic patients [44]. Our
data were in agreement with previous observation that
Table 3 Effect of CAJ and APE supplementation for 21 days on blood glucose levels in experimental animals
Groups Blood glucose (mg/dl)
0 day 3 days after STZ First week Second week Third week
Normal control (NC) 84.23 ± 9.24 89.45 ± 8.12** 89.57 ± 13.99** 81.53 ± 8.62**
Diabetic control (DC) 85.07 ± 5.90 339.01 ± 7.36 374.67 ± 9.87* 408.25 ± 10.50* 432.14 ± 10.31*
Diabetic + CAJ (15 ml/kg) 82.67 ± 8.19 355.77 ± 12.33 134.83 ± 8.19** 99.40 ± 14.33** 87.87 ± 9.64**
Diabetic + APE (1 g/kg) 81.57 ± 8.75 399.23 ± 14.92 90.67 ± 14.30** 88.0 ± 5.23** 105.72 ± 36.10**
The data are expressed as mean ± S.D. of 8 rats in each group
Average in the same column having different superscripts (*, **) indicate significant differences between the values (P <0.05)
Table 4 Effect of CAJ and APE supplementation for 21 days on serum lipid profile in experimental animals
Groups TC (mg/dl) TG (mg/dl) HDL-C (mg/dl) LDL-C (mg/dl) VLDL (mg/dl)
Normal Control (NC) 97.77 ± 20.58** 87.76 ± 23.41** 47.86 ± 4.33** 54.89 ± 2.60** 16.15 ± 5.09**
Diabetic Control (DC) 219.79 ± 2.60* 134.91 ± 32.46* 33.91 ± 6.19* 167.61 ± 8.51* 24.89 ± 5.25*
Diabetic + CAJ (15 ml/kg) 87.93 ± 14.77** 75.41 ± 33.79** 49.01 ± 7.03** 43.27 ± 1.80** 12.48 ± 5.71**
Diabetic + APE (1g/kg) 108.68 ± 14.20** 69.40 ± 21.90** 46.95 ± 8.13** 66.03 ± 3.00** 14.49 ± 4.65**
The data are expressed as mean ± S.D. of 8 rats in each group
Average in the same column having different superscripts (*, **) indicate significant differences between the values (P <0.05)
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STZ-induced diabetic rats showed a significant elevation
of TC, TG, LDL-C, and VLDL-C levels in addition to a re-
duction in HDL-C level. It is known that HDL participates
in the transport of cholesterol from peripheral tissues to
the liver, thus inhibiting the genesis of atherosclerosis [45].
Treatment with CAJ and APE for 21 days was sufficient to
produce a significant decrease in serum TC, TG, LDL-C
and VLDL-C levels suggesting that the polyphenolic com-
ponents of these apple products (CAJ & APE) have a hy-
polipidemic effect. The marked elevation in the level of
HDL suggests a cardio-protective effect of CAJ and APE
treatment. In support for our results, hypolipidimic im-
pact of different polyphenolic compounds was recorded in
Hibiscus sabdariffa plant [46].
Oxygen free radicals have been suggested to ascribe to
the development of complications of diabetes leading to
the cytotoxicity of β-cells. Indeed, several studies have
been carried out to evaluate changes in parameters of
oxidative stress in diabetes [47]. In the present study, an
increase in MDA in the pancreas of STZ-induced rats was
observed when compared with normal control animals.
MDA serves as an index of LPO [48]. Subsequently,
Table 5 Effect of CAJ and APE supplementation for 21 days on lipid peroxidation (MDA) levels and antioxidant enzyme activities in
pancreas of diabetic rats
Groups MDA CAT GR GPx SOD
(μmol/10 mg protein) (nmol/min/10 mg protein) (mU/10 mg protein) (U/10 mg protein) (U/10 mg protein)
Normal Control (NC) 16.94 ± 1.25** 38.09 ± 1.79** 24.47 ± 1.45** 7.16 ± 0.1** 11.21 ± 0.97**
Diabetic Control (DC) 27.08 ± 1.20* 27.36 ± 1.48* 17.79 ± 0.46* 3.54 ± 0.64* 7.23 ± 0.30*
Diabetic + CAJ (15 ml/kg) 20.73 ± 1.35*** 34.35 ± 0.76**** 23.75 ± 1.34** 6.26 ± 0.12**** 9.77 ± 0.16****
Diabetic + APE (1g/kg) 20.45 ± 0.75*** 29.59 ± 1.09*** 20.93 ± 0.77*** 4.92 ± 0.19*** 8.26 ± 0.63***
The data are expressed as mean ± S.D. of 8 rats in each group
Average in the same column having different superscripts (*, **, ***, ****) indicate significant differences between the values (P <0.05)
Fig. 5 The effect of CAJ and APE for 21 days on pancreatic NF-kB, TNF-α, IL-6, and IL-8. Data are expressed as mean ± S.D. of 8 rats in each group.
(NC = normal control group; DC = diabetic control group; DC + CAJ = diabetic group treated with CAJ; DC + APE = STZ-diabetic group treated with
APE. Average in the same parameter having different superscripts (1, 2, 3, 4) indicate significant differences between the values (P <0.05)
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increased MDA level was in agreement with the results of
a previous study [40]. Thus, the increased MDA level in
DM suggests that the hyperglycemia induces the peroxi-
dative reactions in lipids [49]. Supplementation of CAJ
and APE potentially reduced MDA level, suggesting that
CAJ and APE polyphenolic constituents might have anti-
oxidant properties to counteract MDA elevation and pro-
tect the pancreas from diabetic oxidative stress. This
result is in consistent with Ramos who attributed MDA
depletion and oxidative stress rescue effects in cancer to
the presence of dietary polyphenols [50]. This is further
supported by evidence revealing the use of natural extracts
from plant source in rendering the risk of oxidative stress
due to their rich source of phytochemicals [51].
An important consequence of diabetic hyperglycemia
is the enhanced oxidative stress resulting from an imbal-
ance between production and neutralization of ROS by
antioxidant defense system. This imbalance impairs the
cellular functions leading to various pathological condi-
tions and also an alteration in the activity of antioxidant
enzymes, such as CAT, GR, GPx, SOD and disturbed
reduced glutathione [52].
The present data showed that STZ-induced diabetes
impairs actions of pancreatic antioxidant enzymes. The
significant decline in the activities of these enzymes may
be attributed to the accumulation of ROS such as hydro-
gen peroxide (H2O2), superoxide (O2) and hydroxyl (OH
−) [53, 54], which would have otherwise been effectively
scavenged by antioxidant enzymes. CAJ and APE supple-
mentations were significantly potentiated the pancreatic
antioxidative defense and elevated the activities of these
enzymes in diabetic rats (Table 5). This result is in
agreement with Avci et al. who reported that apple con-
sumption increased antioxidant enzymes, including SOD
and GPx in erythrocytes and overall antioxidant poten-
tial in the plasma [55].
It has been found that there is no harmony in the level
of antioxidant enzymes of many organs in diabetic rats.
Although, some studies determining activities of CAT
and SOD in DM exhibited the depletion in the activity
of these enzymes [56, 57], other studies reported the in-
crement in the activity of both enzymes with the STZ-
induced diabetes [58, 59]. SOD is considered a first-line
defense against ROS. This enzyme is present in nearly
all cells, and scavenges the superoxide radicals by con-
verting it to H2O2 [60]. In the present study, the activity
of SOD was found to be lower in pancreatic tissues of
control diabetic rats. The marked depletion in SOD ac-
tivity could be attributed to accumulation of H2O2 or by
glycation of the enzyme which have been reported to
occur in diabetic state [61]. Further CAT, a peroxidase
enzyme, is the most important enzyme involved in the
detoxification of H2O2. The reduction in CAT activity in
control diabetic pancreas tissue could result from
glycation of the enzyme or due to chronic exposure to
H2O2 in vivo [62]. H2O2 may be an essential mediator
for any possible damage in STZ-induced diabetes [63].
The same pattern of results was found for the decreased
activity of GPx. This enzyme catalyzes the reduction of
hydroperoxides at the expense of reduced glutathione
[64]. In the current study, the significantly depletion in
pancreatic CAT, GR, GPx and SOD activities could be
attributed to excessively produced free radicals, which
crosses the scavenging potency of these enzymatic anti-
oxidants in diabetic control rats. Treatment with CAJ
and APE for 21 days, the levels of these pancreatic anti-
oxidant enzymes were significantly augmented in dia-
betic rats which could be attributed to the antioxidative
properties of polyphenolic compounds that were found
in CAJ and APE. The current polyphenolic analysis of
CAJ and APE showed the existence of bioflavonoids that
may exhibit a strong free radical-scavenging activity.
Such antioxidant properties of polyphenols have been
intensively reported [16, 65] and could be ascribed to
not only by the scavenging of free radicals, but also by
the modulation of the mitochondrial function which
represents the major cellular source of ROS [66].
DM propagation is associated with a chain of molecu-
lar events including inflammation which was proven to
be a key factor in this disease [67]. It has been reported
that type 1 DM is an autoimmune disease that is charac-
terized by dysfunction and damage of pancreatic β-cells
which is a consequence of direct contact with immune
cells and of exposure to cytotoxic pro-inflammatory
cytokines as well as other toxic substances [68]. Conse-
quently, the regulation of the intra pancreatic inflamma-
tory markers is an attractive avenue in DM treatment.
NF-kB is considered as a critical key target for allevi-
ation of inflammation and a series of molecular cascades
can be induced by its modulation [69]. NF-kB activity is
induced in response to various cellular physiological
stresses such as DM followed by NF-kB target genes ex-
pression [69]. The current study showed elevated activity
of pancreatic NF-kB after STZ injection in relation to
control samples. This pro-inflammatory response might
be attributed to oxidative stress [70] via ROS production
[16]. It was shown that excessive production of ROS in
adipocytes disturbs endoplasmic reticulum (ER), alters
mitochondrial function and induces inflammatory reac-
tion [71, 72]. ER stress-mediated NF-kB activation was
proven to be dependent on efflux of calcium from ER
followed by production of reactive oxygen intermediates
(ROI) [16].
NF-kB pathway controls the release of both IL-6 and
IL-8 that are involved in DM type 1 development [11]. In
addition, it was demonstrated that both TNF-α and IL-6
are target genes for NF-kB [73, 74]. In the present experi-
ment, STZ increased the levels of pro-inflammatory
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mediators; TNF-α, IL-6 and IL-8. It has been reported that
the levels of pancreatic TNF- α, IL-6 and IL-8 inflamma-
tory cytokines were augmented in STZ-induced diabetic
rats [75, 76]. For further support, IL-6 and TNF-α showed
elevation of their levels in the pancreatic islets of STZ-
induced type 1 rats [77, 78]. TNF-α is an important in-
flammatory mediator which is induced by ROS [16]. It has
been reported that TNF-α has a role in the production of
IL-6 via NF-kB signaling pathway activation [16].
Supplementation of CAJ and APE ameliorated the
levels of inflammatory cytokines in STZ-induced dia-
betic rats. The beneficial impact of CAJ and APE treat-
ments might be due to anti-inflammatory impact of the
recently explored polyphenols of CAJ and APE through
blocking of oxidative stress and mitochondrial damage
[79] as well as free radical scavenging activity leading to
antioxidant enzymes enhancement [80]. In addition, the
suppression of NF-kB activity modulates antioxidant im-
pact which might in turn inhibit the expression of in-
flammatory cytokines [81].
The results of current comprehensive study provide
reasonable information on the Egyptian CAJ and APE
polyphenols. The GC-MS analysis delivers the compos-
ition of the different biomolecules in the Egyptian apple
(CAJ and APE).
Polyphenols are divided into diverse groups according
to the number of phenol rings and the chemical groups
attached to these rings. Flavonoids constitute the most
important group of polyphenols that contain compounds
such as catechin, kaempferol and cyanidine [27]. The
previous components were exhibited in the current work
either in CAJ or APE or both (Tables 1, 2 and Figs. 1, 2,
3, 4). Moreover, other polyphenolic compounds were
recorded by the GC-MS analysis such as emodin and
steviosides in CAJ, pachoulene, sinapic acid, fisetin,
resorcinol, and resveratrol in APE. In addition, Triterpe-
noids including; β-Humulene and Geranyl isovalerate
were detected.
Collectively, the currently detected constituents of
the Egyptian CAJ and APE polyphenols and phyto-
chemicals have been reported to intimately exert anti-
hyperglycemic, antihyperlipidemic, antioxidative and
anti-inflammatory consequences. Catechin is one of
the flavonoids that is proven to effectively reduce lipid
peroxidation and scavenge free radicals [82, 83].
Kaemferol possess antioxidative and hypolipidemic
properties [79]. Cyanidine is one of the naturally oc-
curring anthocyanin that acts as antioxidant via scav-
enging ROS or reactive nitrogen species (RNS),
reducing specific enzymes, chelating trace metals asso-
ciated with the free radical production inducing anti-
oxidant defense, and breaking the free-radical chain
reaction [84, 85]. Emodin treatment significantly re-
duced NF-kB DNA binding activity and the serum
expression levels of TNF-α, IL-6 which led to reduced
pancreatic MDA and increased SOD levels in severe
acute pancreatitis rat model [81]. Stevioside is a nat-
ural sweetener that is proven to exert antihyperglyce-
mic effect due to its capability of scavenging reactive
oxygen species (ROS) and improving antioxidant
response [86]. Fisetin possesses antioxidative, antihy-
perglycemic and anti-inflammatory properties [79].
Sinapic acid markedly reduced lipid peroxidation and
depleted the activation of NF-kB in dimethylnitrosamine-
induced fibrosis in rats [87].
As shown in Tables 1 and 2 as well as in Figs. 1, 2, 3
and 4, all the previous elements are the major phenolic
compounds that are determined in either CAJ and/or
APE. The antihyperglycemic impacts of the Egyptian
CAJ or APE may be contributed by these polyphenolic
components through their antioxidant strengths and
scavenging activities, to restore the antioxidant enzymes
in the pancreas, repair disoriented lipid profile and sup-
press the intra-pancreatic levels of pro-inflammatory
mediators.
Conclusions
From the above findings, we conclude that Egyptian
Anna CAJ and APE possess antihyperglycemic effects by
reduction of the inflammatory response, mitigation of
the oxidative stress, and normalization of the deranged
lipid profile. Thus, Egyptian CAJ and APE may be useful
therapeutic agents that protect from DM.
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